Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians

A Qaseem, V Snow, JT Cross Jr… - Annals of internal …, 2008 - acpjournals.org
Description: The American College of Physicians and American Academy of Family
Physicians developed this guideline to present the available evidence on current …

Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2, Update Alert)

I Sommer, AI Dobrescu, E Persad… - Annals of Internal …, 2024 - acpjournals.org
This first update alert reports surveillance results of the living, rapid evidence review on
“Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the …

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies

YM Mesfin, JE Blais, KT Kibret… - Journal of …, 2024 - academic.oup.com
Objective To determine the effectiveness of nirmatrelvir/ritonavir and molnupiravir among
vaccinated and unvaccinated non-hospitalized adults with COVID-19. Methods …

Sensitivity and Specificity of Using GPT-3.5 Turbo Models for Title and Abstract Screening in Systematic Reviews and Meta-analyses

VT Tran, G Gartlehner, S Yaacoub… - Annals of Internal …, 2024 - acpjournals.org
Background: Systematic reviews are performed manually despite the exponential growth of
scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo …

Outpatient treatment of confirmed COVID-19: living, rapid practice points from the American College of Physicians (version 2)

A Qaseem, J Yost, GM Abraham… - Annals of Internal …, 2023 - acpjournals.org
Description: Evidence for the use of outpatient treatments in adults with confirmed COVID-19
continues to evolve with new data. This is version 2 of the American College of Physicians …

Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation

L Yan, D Bui, Y Li, N Rajeevan… - Clinical Infectious …, 2024 - academic.oup.com
Background Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus
disease 2019 (COVID-19) but remains underutilized. Information on which eligible groups …

Sensitivity, specificity and avoidable workload of using a large language models for title and abstract screening in systematic reviews and meta-analyses

VT Tran, G Gartlehner, S Yaacoub, I Boutron… - medRxiv, 2023 - medrxiv.org
Importance Systematic reviews are time-consuming and are still performed predominately
manually by researchers despite the exponential growth of scientific literature. Objective To …

[HTML][HTML] Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2, Update Alert)

A Qaseem, J Yost, GM Abraham… - Annals of Internal …, 2024 - acpjournals.org
This Update Alert summarizes the impact of new evidence from a surveillance search
relevant to clinical advice presented in the American College of Physicians (ACP) living …

Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity …

H Pinargote-Celorio, Ó Moreno-Pérez… - Journal of …, 2024 - academic.oup.com
Background The effectiveness of the early treatment for antiviral agents in SARS-CoV-2
infection is closely related to patient comorbidities. Data on effectiveness in …